Work

Abstract LB285: HER2 signaling drives drug tolerant persisters to first line amivantamab and lazertinib in EGFR Mutant non small cell lung cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-lb285

Authors: Joosung Gabriel Shim, Youwon Lee, Jii Bumm Lee, Min Hee Hong, Byoung Chul Cho, Sun Min Lim

Institutions: Yonsei University, Yonsei University Health System, Yonsei Cancer Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409820932

Cites:

Cited by: 1

Related to: 10